Maeva May Shares Stroke Association’s New Research Strategy that Launched at UKSF2025
Maeva May, Associate Director of Systems Engagement at Stroke Association, shared on LinkedIn:
”I’m really proud to share the Stroke Association’s new research strategy, which launched yesterday at UKSF2025.
It reflects months of listening to researchers, healthcare professionals, funders and people affected by stroke, alongside a clear-eyed look at the realities of UK stroke research.
Stroke research remains chronically underfunded, and too many promising ideas still take far too long to reach practice.
Yet what has struck me throughout this process is the strength, insight and determination across the stroke community.
This strategy tries to honour that by setting out a practical, ambitious plan to grow research capacity, embed lived experience, and accelerate the journey from discovery to delivery.
For me, this is about more than funding.
It’s about fairness, momentum and making sure that advances in science translate into better outcomes for people whose lives have been upended by stroke.
I’m excited about what we can achieve together.
You can read the strategy and accessible version here.”
Stay updated with Hemostasis Today.
-
Jan 16, 2026, 13:15Paul Bolaji Invites You to Join World Stroke Organization Membership
-
Jan 16, 2026, 12:59Prithu Sundd on The Role of CD39 Polymorphism in Enabling Pulmonary Thrombosis in SCD
-
Jan 16, 2026, 12:46Gregory Piazza on The Effect of Enduring Risk Factors in Provoked VTE
-
Jan 16, 2026, 12:33Fernando Corrales-Medina on Heavy Periods in Teens: Don’t Miss a Bleeding Disorder
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor